La maladie de Parkinson en France (serveur d'exploration) - Analysis (USA)

Index « Auteurs » - entrée « Bertrand Bloch »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Bertram Müller-Myhsok < Bertrand Bloch < Bertrand Duchiron  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000536 (2009) Stefan Schuster [Allemagne] ; Evelyne Doudnikoff [France] ; Daniella Rylander [Suède] ; Amandine Berthet [France] ; Incarnation Aubert [France] ; Carina Ittrich [Allemagne] ; Bertrand Bloch [France] ; M. Angela Cenci [Suède] ; D. James Surmeier [États-Unis] ; Bastian Hengerer [Allemagne] ; Erwan Bezard [France]Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
000677 (2005) Céline Guigoni ; Sandra Dovero ; Incarnation Aubert [France] ; Qin Li [République populaire de Chine] ; Bernard H. Bioulac ; Bertrand Bloch [France] ; Eugenia V. Gurevich [États-Unis] ; Christian E. Gross ; Erwan BezardLevodopa‐induced dyskinesia in MPTP‐treated macaques is not dependent on the extent and pattern of nigrostrial lesioning
000847 (1999) Marie-Paule Muriel [France] ; Véronique Bernard [France] ; Allan I. Levey [États-Unis] ; Ouahiba Laribi [France] ; D. Nora Abrous [France] ; Yves Agid [France] ; Bertrand Bloch [France] ; Etienne C. Hirsch [France]Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease
000849 (1999) Mohamed Jaber [France] ; Brigitte Dumartin [France] ; Corinne Sagné [France] ; John W. Haycock [États-Unis] ; Christine Roubert [France] ; Bruno Giros [France] ; Bertrand Bloch [France] ; Marc G. Caron [États-Unis]Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Antiparkinson agent
2Neuron
2Parkinson disease
1Abnormal movement
1Aged
1Aged, 80 and over
1Animal
1Animal model
1Animals
1Chemotherapy
1Corpus Striatum (metabolism)
1Corpus striatum
1Cytoplasm
1D1 Dopamine receptor
1DOPA decarboxylase
1Development
1Dopa
1Dyskinesia
1Electron microscopy
1Human
1Humans
1Immunohistochemistry
1Involuntary movement
1Isradipine
1L-type calcium channel
1Levodopa
1Localization
1Male
1Motor control
1Oxidopamine (metabolism)
1Parkinson Disease (metabolism)
1Parkinson's disease
1Rat
1Rats
1Rats, Wistar
1Receptors, Dopamine D1 (metabolism)
1Treatment
1dopamine transporter
1immunohistochemistry
1knock‐out
1striatum
1substantia nigra
1tyrosine hydroxylase
1vesicular monoamines transporter

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Bertrand Bloch" 
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i  \
                -Sk "Bertrand Bloch" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Bertrand Bloch
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024